Reduce stroke risk and lower blood pressure by eating 5 common foods every week
According to the NHS, "a stroke is when blood stops flowing to a part of your brain. It can affect things like speech and movement, and it can take a long time to recover. A stroke needs urgent medical help in a hospital because it can be life-threatening."
Fortunately, many strokes are largely preventable, especially with healthy lifestyle choices, including what you eat. Health expert, Vanessa King, M.S., RDN, shared: "Eating well plays a supportive role in reducing stroke risk and supporting recovery after a stroke."
READ MORE: Cardiologist says four changes slash cholesterol better than statins
READ MORE: 'Remarkable' snack flushes out fats and sugars and 'adds years to life'
Medical studies have shown that "those with the highest-quality diets (as determined by the Alternative Healthy Eating Index) had a 40% lower risk of stroke compared to those with the lowest-quality diets," reported Eating Well.
In fact, regularly eating just four common foods, including one unexpected caffeinated drink, may significantly reduce your risk of stroke. These aren't exotic superfoods that are hard to find; they are everyday items you might already have in your kitchen.
Fish is a major superfood for the brain. It is rich in omega-3 fatty acids and other heart-healthy nutrients that can help lower blood pressure and support the health of your blood vessels.
Health expert Vanessa highlighted: "Three ounces of cooked salmon is a great source of vitamins B6 and B12, providing 23% of the Daily Value of B6 and over 100% of the Daily Value of B12."
"These B vitamins may lower total blood homocysteine concentrations—a key risk factor for stroke."
The expert recommends eating salmon with salads like Salad Niçoise or making a baked dish.
Chickpeas are packed with nutrients that support brain health. Their high fibre and protein content is one of the biggest reasons why they may help reduce stroke risk.
Vanessa shared: "A cup of these versatile beans adds 10% of the Daily Value of homocysteine-lowering vitamin B6. And since they come conveniently precooked, it's easy to crack open a can to upgrade nutrition in your meals.
"They serve as a fibre-rich protein source for stews, salads, curries and snacks."
Speaking to Eating Well, another health expert, Amy Brownstein, debunked misconceptions about soy food
She said: "Soy proteins lower blood pressure. They're naturally low in fat, and compounds like phytoestrogens and isoflavones positively influence blood pressure by potentially relaxing blood vessels."
However, meat eaters do not need to completely change their diet to soy to promote positive blood pressure, but the expert recommends replacing one meat-based meal a week with a soy dish.
Spinach is one of the best greens to incorporate into your diet as its nutrients, such as potassium, magnesium, and folate, help promote blood flow into your brain.
"A half-cup of cooked spinach is a great source of folate and a good source of magnesium," said Vanessa.
According to Healthline, when you eat leafy greens such as spinach, your body converts the nitrates into nitric oxide, which plays an important role in regulating blood flow and blood pressure.
"A 2021 study found that consuming at least 60 milligrams (mg) per day of vegetable nitrate (1 cup of leafy green vegetables) led to a 17% reduced risk of ischemic stroke."
Surprisingly, health experts have recommended drinking coffee as a part of a healthy diet due to its ability to lower blood pressure levels.
Amy Brownstein highlighted: "Besides its caffeine content, coffee is a significant source of polyphenols like chlorogenic acid, which may contribute to lower blood pressure levels."
However, limiting your sweeteners is recommended as studies show that added sugars can contribute to stroke risk. Too much sugar can also lead to diabetes.
Diabetes can increase the risk of a stroke because having too much sugar in the blood damages the blood vessels, according to stroke.org.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Pfizer battles another Paxlovid lawsuit from Enanta
If you don't succeed at first, try again – in separate regions. That's the motto Enanta Pharmaceuticals is following, at least, after disclosing it has sued Pfizer in Europe over a patent infringement relating to Covid-19 treatment pill Paxlovid (nirmatrelvir/ritonavir). In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma company infringed on a patent describing protease inhibitors invented by its scientists. Enanta has now followed that up with another filing in Europe, making the same accusation. Since being emergency authorised in 2021, anti-viral Paxlovid has generated Pfizer more than $26bn in global revenue. This includes a staggering $18.9bn in 2022 when Covid-19 cases were still prevalent. Despite waning demand for Covid-19 treatments, the pill still brought in $1.2bn in 2024, buoyed by government orders. However, Enanta – known for co-developing hepatitis C virus treatment glecaprevir/pibrentasvir with AbbVie – believes Pfizer designed Paxlovid via unlawful means. The US biotech stated it is 'seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's Covid-19 antiviral, Paxlovid'. In an emailed statement to Pharmaceutical Technology, a Pfizer spokesperson said: 'We are confident in our intellectual property (IP) surrounding Paxlovid and will respond in due course in court.' The lawsuit, filed in the European Union's (EU) Unified Patent Court (UPC), targets Pfizer's commercial activity in the 18 countries of the EU. The company confirmed the '265 patent in question is the European counterpart of US patent number 11,358,953 (the '953 Patent) that is the centre of the US lawsuit. Although it is technically ongoing, Enanta's US lawsuit hit a major roadblock. In December 2024, a federal judge in Massachusetts sided with Pfizer, granting that the '953 patent is invalid. Enanta confirmed at the time it would appeal the decision, adding it 'believes strongly in the merits of our case'. Pfizer reported strong Q2 2025 results this month, bucking a tepid earnings window that gripped the wider pharma industry. Sales for the Paxlovid grew 71% while the Covid-19 vaccine Comirnaty revenue surged 95%. However, the legal challenge posed by Enanta marks the second issue Pfizer has had to firefight this week. The big pharma company reported a Phase III trial failure for a sickle cell disease candidate purchased as part of a $5.4bn takeover of Global Blood Therapeutics in 2022. "Pfizer battles another Paxlovid lawsuit from Enanta" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Wall Street Journal
17 minutes ago
- Wall Street Journal
‘What Doesn't Kill Us' Review: Freeze Your Enthusiasm
In 2017 the investigative journalist Scott Carney wrote 'What Doesn't Kill Us.' The book featured Wim Hof, an unorthodox health trainer from Holland who could push people (including Mr. Carney) past previously unthinkable physical barriers. The book became a bestseller and helped transform Mr. Hof into a celebrity, popularizing his training methods—particularly cold plunges, which involve immersing oneself in frigid water for a few minutes at a time. Capitalizing on the sales of 'What Doesn't Kill Us,' in 2020 Mr. Hof wrote his own book, which has been translated into multiple languages. Never mind that Mr. Carney's book came with an ominous full-page disclaimer, warning that the practices described in the book 'are inherently dangerous and could result in grave harm or death.' It's tempting to dismiss the foreboding tone as a publicity stunt to juice sales. But since then, Mr. Carney tells us in a new edition of his book, he has 'collected more than thirty reports of people who have drowned while following Hof's example by practicing his breathwork techniques in water.' In a 15-page afterword to the new edition, Mr. Carney tells us that Mr. Hof's representatives respond by insisting there are warnings—for instance, in the descriptions attached to Mr. Hof's demonstration videos on YouTube—against using his breathing techniques 'in a swimming pool, before going underwater, beneath the shower, or piloting any vehicle.' Mr. Carney isn't convinced, citing a video marketed by Mr. Hof in which he contradicts his own guidance. 'At the very least, the juxtaposition between the written warning and Hof's own words is confusing. At worst, it's a dramatic acknowledgment of the sort of negligence that could get someone killed.'
Yahoo
44 minutes ago
- Yahoo
Midwife brings claim against trust after ‘Prevent referral over Palestine posts'
A midwife is bringing an employment claim against a hospital trust she worked for after it lodged a Prevent referral with police over her online support for Palestine and criticism of Zionism, her lawyers have said. Chelsea and Westminster Hospital NHS Foundation Trust made the referral to the Home Office's early intervention counter-terrorism programme, along with one to the Nursing and Midwifery Council regulator, a year after Fatimah Mohamied had resigned from her employment and following a complaint about her online activity from UK Lawyers for Israel (UKLFI), according to law firm Leigh Day. The mother-of-two, who lives in London, alleges the referrals breach her rights under the Equality Act 2010 and constitute post-employment harassment and/or discrimination. She said: 'I have been subjected to a concerted and targeted effort to intimidate, harass and punish me into silence for my Palestinian advocacy and criticism of Zionism. 'I am taking legal action against my former employer to finally seek accountability for a campaign of harassment against me in the midst of a live genocide perpetrated by the Israeli state – I will not accept the attempts to silence me and those like me. 'Healthcare workers in the NHS have the right to critique a colonial political ideology that has upheld an illegal occupation for decades and is responsible for violating universal values of health.' A complaint was lodged on October 8 2023 about Ms Mohamied's social media posts in which she voiced her support for Palestinian people and her opposition to Zionism in the wake of the October 7 attacks in Israel, according to Leigh Day. Her line manager asked her to consider deleting the posts or her account but she refused to do so. Three further complaints were made about the midwife's social media posts and on December 20 2023 the trust received a letter from UKLFI accusing Ms Mohamied of expressing support for Hamas. In early January the following year, the trust's director of maternity told Ms Mohamied that if they received 'more emails or letters of concern' her actions could be considered misconduct. Ms Mohamied, who was employed as a 'cultural safety lead' midwife and who had worked at the trust since June 2019, resigned in March last year. In March of this year, the trust received a second letter from UKLFI which launched further complaints about further social media posts and accused Ms Mohamied of anti-semitism, bullying and harassment and of stirring up racial hatred against Jews and Israelis. Towards the end of the month, the trust referred Ms Mohamied to the Nursing and Midwifery Council and then to the Metropolitan Police under Prevent over her online activity. Both referrals were dismissed, and Leigh Day said in a letter to the trust that the regulator and police each assessed Ms Mohamied's posts 'amounted to lawful expression of her beliefs and did not present cause for concern'. Liana Wood, partner at the law firm, said: 'We say the trust's referrals against Fatimah, made a year after she had stopped working for them, were an entirely disproportionate response to her lawful expressions of belief on her personal blog and social media accounts. 'Fatimah's case, which has parallels with other cases we have seen recently in the NHS, highlights the need for employers to resist pressure from lobby groups in such cases, and to carefully consider any potential infringement on an individual's rights before taking action against them.' The hospital trust has been contacted for comment.
